Cargando…
Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy
Leber's hereditary optic neuropathy (LHON) is a disease that leads to blindness. Gene therapy has been investigated with some success, and could lead to important advancements in treating LHON. This was a prospective, open-label trial involving 9 LHON patients at Tongji Hospital, Wuhan, China,...
Autores principales: | Yang, Shuo, Ma, Si-qi, Wan, Xing, He, Heng, Pei, Han, Zhao, Min-jian, Chen, Chen, Wang, Dao-wen, Dong, Xiao-yan, Yuan, Jia-jia, Li, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006665/ https://www.ncbi.nlm.nih.gov/pubmed/27426279 http://dx.doi.org/10.1016/j.ebiom.2016.07.002 |
Ejemplares similares
-
Efficacy and Safety of rAAV2-ND4 Treatment for Leber’s Hereditary Optic Neuropathy
por: Wan, Xing, et al.
Publicado: (2016) -
The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy
por: Zhang, Yong, et al.
Publicado: (2018) -
Evaluation of Leber's hereditary optic neuropathy patients prior to a gene therapy clinical trial
por: Yang, Shuo, et al.
Publicado: (2016) -
Developments in the Treatment of Leber Hereditary Optic Neuropathy
por: Chen, Benson S., et al.
Publicado: (2022) -
A retrospective analysis of characteristics of visual field damage in patients with Leber’s hereditary optic neuropathy
por: Ran, Ruijin, et al.
Publicado: (2016)